<--- Back to Details
First PageDocument Content
GnRH agonists / Degarelix / Prostate cancer / Goserelin / Antiandrogen / Triptorelin / Buserelin / Ferring Pharmaceuticals / Gonadotropin-releasing hormone agonist / Prostate / Management of prostate cancer / Androgen deprivation therapy
Date: 2015-06-17 10:44:39
GnRH agonists
Degarelix
Prostate cancer
Goserelin
Antiandrogen
Triptorelin
Buserelin
Ferring Pharmaceuticals
Gonadotropin-releasing hormone agonist
Prostate
Management of prostate cancer
Androgen deprivation therapy

Microsoft Word - DSU Degarelix FINAL sent to NICE

Add to Reading List

Source URL: www.nicedsu.org.uk

Download Document from Source Website

File Size: 194,14 KB

Share Document on Facebook

Similar Documents

GnRH agonists / Degarelix / Prostate cancer / Goserelin / Antiandrogen / Triptorelin / Buserelin / Ferring Pharmaceuticals / Gonadotropin-releasing hormone agonist / Prostate / Management of prostate cancer / Androgen deprivation therapy

Microsoft Word - DSU Degarelix FINAL sent to NICE

DocID: 1oZJA - View Document

Zmeny v Zozname zakázaných látok 2016 Trvalo zakázané látky a metódy S2. Peptidové hormóny, rastové faktory, príbuzné látky a mimetiká Leuprorelín nahradil triptorelín ako univerzálnejší príklad ch

DocID: 1n149 - View Document

High doses of triptorelin needed for ovarian suppression in SLE

DocID: 1ddi4 - View Document

Progestagens / Drugs / Triptorelin / Prostaglandin E2 / Terlipressin / Endometrin / Atosiban / Degarelix / Growth hormone treatment / Endocrine system / Medicine / Peptides

Microsoft Word - About Ferring - fact sheet_31Mar15.doc

DocID: 143Ql - View Document

Triptorelin / West Ryde /  New South Wales / Deslorelin / Gonadotropin-releasing hormone analogue / Gonadotropin-releasing hormone agonist / Gonadotropin-releasing hormone / Biology / Medicine / GnRH agonists / Fertility medicine / Suburbs of Sydney

AUSTRALIAN PESTICIDES & VETERINARY MEDICINES AUTHORITY Application Summary for Application No[removed]Application Details: Product Name:

DocID: VB1H - View Document